MGNX – macrogenics, inc. (US:NASDAQ)

News

MacroGenics (MGNX) was upgraded by B. Riley Financial, Inc. from "neutral" to "buy". They now have a $9.00 price target on the stock.
FDA Removes Partial Clinical Hold on MacroGenics' LINNET Study [Yahoo! Finance]
FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study
MacroGenics, Inc. (MGNX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]
MacroGenics (MGNX) Reports Q4 Loss, Tops Revenue Estimates [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com